Author

J. C. Hernandez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Ecology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

L. Florez-Alvarez· 2 shared W. Zapata-Builes· 2 shared A. Guerra-Sandoval· 1 shared A. Ossa-Giraldo· 1 shared C. Guerra-Almonacid· 1 shared J. Hincapie-Garcia· 1 shared J. I. Arroyo· 1 shared K. Contreras-Ramirez· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L. Florez-Alvarez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

EcologybioRxivPreprintJun 25, 2023

Foraging specialization and body size in seabirds

J. C. Hernandez, J. I. Arroyo

The paper examines the relationship between seabird body size and foraging specialization, finding negative scaling exponents and proposing a model based on ecological principles.

DOI 10.1101/2023.06.25.546462

multiple speciesstatistical model

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 11, 2021

Seronegative MSM at high-risk of HIV-1 acquisition show Immune quiescent profile with normal immune response against common antigens

A. Ossa-Giraldo, Y. Blanquiceth, L. Florez-Alvarez…·W. Zapata-Builes

This study compares the immunological profiles of high-risk and low-risk HIV-negative MSM, finding a quiescent immune profile and increased Serpin A1 expression in high-risk individuals.

DOI 10.1101/2021.03.11.434877

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintMar 1, 2021

Atorvastatin effectively inhibits late replicative cycle steps of SARS-CoV-2 in vitro

M. I. Zapata-Cardona, L. Florez-Alvarez, W. Zapata-Builes…·J. C. Hernandez

This paper evaluates atorvastatin's in vitro antiviral effect against SARS-CoV-2, showing inhibition of late replicative cycle steps and favorable binding affinity with viral proteins.

DOI 10.1101/2021.03.01.433498

virusstatistical model

𝕏 PostBluesky